NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
0.55
-0.05 (-9.06%)
At close: Aug 15, 2025, 3:30 PM
0.62
13.30%
After-hours: Aug 15, 2025, 03:58 PM EDT
NovaBay Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 3.54M | -7.22M | -10.12M | -10.54M | -10.99M | -9.64M | -13.74M | -12.12M | -12.24M | -10.61M | -2.56M | -4.71M | -4.42M | -5.82M | -7.42M | -8.35M | -10.97M |
Depreciation & Amortization | 170K | 127K | 82K | 124K | 164K | 203K | 276K | 344K | 413K | 483K | 447K | 340K | 231K | 119K | 43K | 43K | 46K |
Stock-Based Compensation | 90K | 148K | 227K | 267K | 276K | 291K | 291K | 21K | 111K | 220K | 578K | 1.01M | 1.15M | 1.15M | 878K | 1.03M | 825K |
Other Working Capital | 832K | 742K | 407K | -60K | -27K | 132K | 39K | 126K | 290K | 260K | 195K | 8.57M | 18.82M | 18.6M | 18.9M | 10.19M | -662K |
Other Non-Cash Items | -56K | 1.25M | 4.46M | 5.76M | 5.86M | 4.8M | 7.16M | 5.72M | 5.58M | 3.06M | -6.57M | -6.09M | -6.42M | -4.03M | 102K | 59K | 85K |
Deferred Income Tax | n/a | n/a | 531K | 246K | 246K | n/a | -531K | -246K | -586K | -340K | -813K | -813K | -473K | -473K | n/a | 1.6M | 5.41M |
Change in Working Capital | 172K | 229K | 537K | 1.44M | 805K | 750K | 1.51M | -79K | 511K | 533K | -846K | 707K | 79K | -38K | 173K | -496K | -560K |
Operating Cash Flow | -4.92M | -5.18M | -4.53M | -2.94M | -4.11M | -4.13M | -5.03M | -6.35M | -6.21M | -6.65M | -9.76M | -9.54M | -9.83M | -9.19M | -6.32M | -6.22M | -5.28M |
Capital Expenditures | -4K | -6K | -8K | -8K | -8K | -19K | -49K | -127K | -133K | -144K | -120K | -57K | -51K | -52K | -65K | -53K | -51K |
Cash Acquisitions | -1.07M | n/a | 1.07M | 1.07M | 1.07M | n/a | n/a | n/a | n/a | n/a | -11.99M | -11.99M | -11.99M | -11.99M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 1.07M | 1.07M | 1.07M | 1.07M | n/a | n/a | n/a | n/a | n/a | -11.99M | -11.99M | -11.99M | -11.99M | n/a | n/a | n/a |
Investing Cash Flow | -1.07M | -6K | 1.06M | 1.06M | 1.06M | -19K | -49K | -127K | -133K | -144K | -12.11M | -12.05M | -12.04M | -12.04M | -65K | -53K | -51K |
Debt Repayment | -912K | -1.49M | -1.99M | -1.2M | 2.23M | 2.81M | 2.81M | 2.81M | n/a | n/a | 105K | 105K | 105K | 105K | n/a | n/a | -1.55M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -218K | -218K | -218K | -218K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.89M | 2.88M | 2.96M | -492K | -916K | -897K | 2.16M | 4.44M | 4.74M | 4.63M | 16.51M | 14.8M | 16.58M | 16.68M | 1.78M | 7.79M | 11.68M |
Financial Cash Flow | 2.08M | 1.5M | 976K | -1.69M | 1.22M | 1.8M | 4.97M | 7.25M | 4.63M | 4.53M | 16.29M | 14.8M | 16.68M | 16.79M | 2M | 7.79M | 10.13M |
Net Cash Flow | 6.64M | -2.7M | -2.69M | -3.66M | -1.92M | -2.24M | -72K | 804K | -1.57M | -2.13M | -5.48M | -6.68M | -5.19M | -4.45M | -4.38M | 1.52M | 4.8M |
Free Cash Flow | -4.92M | -5.19M | -4.42M | -2.84M | -4.01M | -4.04M | -5.08M | -6.48M | -6.34M | -6.8M | -9.88M | -9.6M | -9.88M | -9.24M | -6.38M | -6.27M | -5.33M |